Weekly Trade Information-154
One of the "Three Delicacies of Vegetarian Diet," the market value of edible daylilies has reached USD 1 billion.
Daylily (Hemerocallis citrina Baroni), also known as golden needles, lemon daylily, or forget-sorrow grass, is a perennial herbaceous plant. Its flower buds can be eaten fresh or dried and are celebrated alongside mushrooms and wood ear fungus as one of the "Three Delicacies of Vegetarian Diet." Daylily buds are highly prized as a gourmet vegetable in Asian cuisine. The cultivation history of daylilies dates back 2,500 years. Beyond culinary uses, daylily buds have long been employed in traditional medicine. For instance, the Compendium of Materia Medica records their use for promoting lactation, while the Chinese Pharmacopoeia documents their efficacy in improving sleep. Modern research using daylily extracts has demonstrated their potential to alleviate certain human ailments. Bioactive compounds extracted from daylilies exhibit antibacterial, antioxidant, and nitrite-eliminating properties. Due to their rich nutritional profile and potential medicinal value, demand for daylilies is rapidly growing. It is estimated that the market value of daylilies has reached USD 1 billion in recent years.(Source: FTA)
Key Benefits and Functions of Inulin
Inulin is a naturally occurring polysaccharide primarily sourced from plants in the Asteraceae, Campanulaceae, and Gentianaceae families, including Jerusalem artichokes, chicory, onions, and garlic. It serves as a high-quality water-soluble dietary fiber and an effective prebiotic.
Inulin Promotes Gut Health:
Inulin is broken down by probiotics in the gut into short-chain fatty acids (e.g., propionic acid, butyric acid), which help maintain normal intestinal pH balance and enhance gut microbiota health.
It increases populations of beneficial bacteria (such as Bifidobacteria), improves the gut microecological environment, stimulates intestinal peristalsis, and increases stool volume—thereby alleviating constipation.
Additionally, inulin aids in water absorption within the intestines, maintaining mucosal hydration and reducing the occurrence of intestinal inflammation.
(Source: Chemical Book)
Fuyang Biotechnology Secures Allulose Production License and Launches Domestic Market Strategy
Recently, Fuyang Biotechnology has successfully obtained the production license for allulose and initiated its domestic market deployment.
This approval follows the National Health Commission's latest announcement (No. 4, 2025), which formally recognizes allulose as a novel food ingredient and specifies two approved production methods:
Fermentation Method:
Produced by fermenting glucose or sucrose using Escherichia coli AS10, followed by refining processes.
Enzymatic Conversion Method:
Catalyzed by D-allulose-3-epimerase (from approved sources), fructose undergoes multi-step conversion to yield allulose.
Fuyang Biotechnology's production process aligns with the "Enzymatic Conversion Method" and complies with isomerase requirements, fulfilling prerequisites for licensing. The company now stands among China's first licensed allulose manufacturers.
(Source: WeiGao Daily)
AI + Microbial Fermentation Technology Drives Probiotics Industry Upgrade
The "AI Strain Optimization Platform" co-developed by China's BGI and Mengniu Group has successfully boosted probiotic fermentation efficiency by 50%. This system utilizes deep learning to analyze genomic data from over 100,000 bacterial strains, accurately predicting optimal culture conditions. Key achievements include:
3× increase in yield of Bifidobacterium lactis BL-04
30% reduction in production costs
Currently applied in new-generation gut-regulating yogurt, with mass production expected by late 2025. The AI system also enables real-time monitoring of critical fermentation parameters (pH, dissolved oxygen levels) to maintain microbial viability stability.
(Sources: Nature Biotechnology)
Europe's "Cell-Cultured Collagen" Approved for Market, Replacing Animal-Derived Ingredients
German biotech company CollagenTech's cell-cultured collagen peptide was approved by the EU's EFSA in May 2025, becoming the world's first non-animal-derived collagen for use in health foods. The technology uses gene-edited human fibroblasts to produce Type I & III collagen on a large scale in bioreactors, achieving up to 99% purity and eliminating the risk of viral residues. The product has been applied in joint health oral liquids and skin repair powders, with plans to enter the Asian market in 2026.
(Sources: EFSA Safety Assessment Report, CollagenTech Press Conference)
Service Upgrade | MSC Adjusts Asia-US West Coast Routes
In response to current trans-Pacific market conditions, MSC will temporarily suspend PERAL service until further notice. Accordingly, the following adjustments are made to SENTOSA and ORIENT services:
ORIENT Service Upgrade
To enhance coverage, ORIENT will add Haiphong, Vietnam to its rotation. New port sequence:
Haiphong → Ningbo → Shanghai → Busan → Long Beach → Oakland
SENTOSA Service Adjustment
To maintain Xiamen-US West Coast connectivity, SENTOSA (Eastbound) will add Xiamen. New rotation:
Port Klang → Singapore → Laem Chabang → Vung Tau → Yantian → Xiamen → Long Beach → Oakland
(Source: 5688.CN)
Weekly Trade Information-155
Weekly Trade Information-153
Related Article
Rising Demand for Stabilizing and Suspending Systems in Plant-Based Beverages Drives Segmented Gellan Gum Applications
Dual Mainstream: Precision Nutrition and Clean Label
Expanding Applications of Gellan Gum, with Plant‑Based Beverages as a Key Growth Segment
VC Manufacturers Halt Quotations Collectively; Market Rises by 5‑8% Within One Day
